Gregory Astrachan > Willkie Farr & Gallagher LLP > New York, United States > Lawyer Profile

The ‘smart, hardworking, and experienced’ practice at Willkie Farr & Gallagher LLP is comprised of skilled attorneys capable of handling a wide array of transactional issues, ranging from complex leveraged buyouts to minority investments. The focal point of the firm’s expertise revolves around the asset management, finance, and healthcare sectors, with the New York-based leading trio of David Boston, Russell Leaf, and Adam Turteltaub bringing in-depth knowledge on all types of acquisitions and corporate governance matters to the offering. Steven Seidman focuses on securities law issues, Thomas Cerabino is knowledgeable on joint ventures, and the ‘outstanding’ Gregory Astrachan frequently advises on transactions in the insurance and financial services sectors. Rosalind Fahey Kruse and Houston-based Aaron Savella are also noted as key.

Willkie Farr & Gallagher LLP has an impressive mix of investment grade, high-yield and convertible debt engagements. Healthcare, financial services and insurance are key sectors for the firm. It also advises a number of private equity houses and their portfolio companies, including in note offerings connected to acquisitions. New York partners Cristopher Greer and Gregory Astrachan co-chair the capital markets group. Edward Best  and John Ablan arrived in Chicago from Mayer Brown in August 2024.

Willkie Farr & Gallagher LLP has a prestigious history in high-yield debt offerings connected to M&A and private equity buyouts. Among other clients, the firm frequently advises Platinum Equity and its portfolio companies on debt offerings to support acquisitions. The capital markets team is best known for issuer-side representation and is notably active in technology and healthcare sector offerings. Cristopher Greer and Gregory Astrachan are key names, based in New York. Edward Best  and John Ablan joined the team in Chicago from Mayer Brown in August 2024.